Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2 Gastrointestinal 2 Breast 2 Tumor-Agnostic 1 Thoracic 1 Other neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 Genitourinary 1

Conditions

Interventions

Cyclophosphamide 13 Peripheral Blood Stem Cell Transplantation 9 Biopsy 9 fludarabine phosphate 8 Busulfan 8 Whole-Body Irradiation 7 Surveys and Questionnaires 6 Mycophenolic Acid 6 Educational Status 6 Early Intervention, Educational 6 Carboplatin 6 fludarabine 5 Tacrolimus 5 Paclitaxel 5 Methotrexate 5 Methods 5 Melphalan 5 Epoetin Alfa 5 Decitabine 5 Cyclosporine 5 Colposcopy 5 Cisplatin 5 Celecoxib 5 Antilymphocyte Serum 5 Aminolevulinic Acid 5 Sulindac 4 Selenium 4 Radiotherapy 4 Patient Reported Outcome Measures 4 Magnetic Resonance Spectroscopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Psychotherapy × Other neoplasm × Clear all

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡